Pfizer Product Theater

Pfizer_Logo_Color_RGB_2021.png

Date: Thursday, November 4, 2021 
Time: 8 PM ET

A Clinical Overview of a Prescription Treatment for Patients With Moderately to Severely Active Ulcerative Colitis


This program is sponsored by Pfizer


Intended for US HCPs

Jennifer Seminerio-Diehl will discuss the clinical data and safety profile of a prescription treatment for adult patients with moderately to severely active ulcerative colitis.


Speaker: Jennifer Seminerio-Diehl, MD